AC
AGN

Ascend Capital’s Allergan plc AGN Stock Holding History

Ascend Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$10.5M Buy
+55,000
New +$10.1M 0.53% 65
2018
Q1 		– Sell
-29,371
Closed -$4.8M – 290
2017
Q4 		$4.8M Buy
+29,371
New +$5.27M 0.18% 123
2017
Q2 		– Sell
-22,298
Closed -$5.33M – 202
2017
Q1 		$5.33M Buy
+22,298
New +$5.19M 0.24% 96
2016
Q2 		– Sell
-50,000
Closed -$13.4M – 167
2016
Q1 		$13.4M Buy
+50,000
New +$14.3M 1.28% 29
2015
Q4 		– Sell
-162,811
Closed -$44.3M – 181
2015
Q3 		$44.3M Buy
162,811
+78,415
+93% +$24.1M 1.74% 19
2015
Q2 		$25.6M Sell
84,396
-117,708
-58% -$35.1M 0.84% 45
2015
Q1 		$60.2M Buy
202,104
+53,919
+36% +$15.4M 2.07% 10
2014
Q4 		$38.1M Sell
148,185
-4,437
-3% -$1.11M 1.46% 18
2014
Q3 		$36.8M Sell
152,622
-34,883
-19% -$7.81M 1.09% 29
2014
Q2 		$41.8M Sell
187,505
-5,320
-3% -$1.1M 1.39% 16
2014
Q1 		$39.7M Buy
192,825
+117,725
+157% +$23.3M 1.03% 33
2013
Q4 		$12.6M Buy
75,100
+20,372
+37% +$3.18M 0.38% 85
2013
Q3 		$7.88M Buy
54,728
+4,689
+9% +$625K 0.29% 109
2013
Q2 		$6.32M Buy
+50,039
New +$5.67M 0.27% 106

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ascend Capital's AGN Position: Q3 2018 in Review

Ascend Capital opened a new position in Allergan plc (AGN) in Q3 2018: 55,000 shares worth $10.5M. The stake represents 0.53% of the portfolio and ranks #65 among its holdings. This is a return to the name: Ascend Capital previously reported a position in AGN as recently as Q4 2017.

Ascend Capital first reported a position in AGN in Q2 2013 and has held it in 14 quarters since. The position peaked at $60.2M in Q1 2015. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Ascend Capital held 55,000 shares of Allergan plc worth $10.5M as of Q3 2018.
  • Allergan plc was a new Ascend Capital position in Q3 2018.
  • Allergan plc made up 0.53% of Ascend Capital's portfolio in Q3 2018, its #65 holding.
  • Ascend Capital first reported a position in Allergan plc in Q2 2013 and has held it in 14 quarters since.
  • Ascend Capital's Allergan plc position peaked at $60.2M in Q1 2015.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.